From Risk to Resilience: How Medtech Firms Are Adapting to Tariff Uncertainty eBook
Recent shifts in global trade policy, particularly under the current U.S. administration, are contributing to heightened uncertainty across international markets. Newly announced U.S. tariffs on imports from countries are expected to have a cascading effect throughout the medtech value chain.
In response, companies may need to diversify suppliers or relocate manufacturing operations, which could result in delays, higher logistics expenses, and operational disruption. Rising operational costs may also prompt budget tightening, potentially slowing R&D investment and extending product development timelines. These dynamics may also shape future investment decisions and drive further restructuring of global supply chains.
Read our eBook to access expert analysis, data and a deep dive on the quickly changing landscape including:
- An overview of the shifts in global trade policy
- The impact on and major materials impacted in the Orthopedic Device industry
- The impact on and major materials impacted in the Cardiovascular Device Industry
- Mitigation strategies adopted by key players
- How the medtech industry can effectively chart a path forward
